The effect of debrisoquin on MAO A and MAO B activities

Martin A Javors, M. E. Bembenek, C. L. Bowden, C. W. Abell, J. W. Maas

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

To examine the mode of action of debrisoquin (DEB), we studied the effect of this drug in vitro on MAO A and MAO B enzyme activities. DEB was shown to be a competitive inhibitor of highly purified human MAO A and MAO B enzyme activities. DEB inhibited placental MAO A with a Ki value of 0.5 μM and liver MAO B with a Ki value of 8.8 μM, 18-fold greater effect on the A form. Kynuramine was used as substrate for both enzymes. Additional studies using a dilution technique showed that DEB was a reversible inhibitor of both forms of the enzyme. The results of this study show that DEB is a potent competitive and reversible inhibitor of both MAO A and MAO B enzymes.

Original languageEnglish (US)
Pages (from-to)2359-2364
Number of pages6
JournalLife Sciences
Volume45
Issue number24
DOIs
StatePublished - 1989

Fingerprint

Debrisoquin
Monoamine Oxidase
Enzymes
Enzyme activity
Kynuramine
Indicator Dilution Techniques
Liver
Dilution

ASJC Scopus subject areas

  • Pharmacology

Cite this

Javors, M. A., Bembenek, M. E., Bowden, C. L., Abell, C. W., & Maas, J. W. (1989). The effect of debrisoquin on MAO A and MAO B activities. Life Sciences, 45(24), 2359-2364. https://doi.org/10.1016/0024-3205(89)90118-5

The effect of debrisoquin on MAO A and MAO B activities. / Javors, Martin A; Bembenek, M. E.; Bowden, C. L.; Abell, C. W.; Maas, J. W.

In: Life Sciences, Vol. 45, No. 24, 1989, p. 2359-2364.

Research output: Contribution to journalArticle

Javors, MA, Bembenek, ME, Bowden, CL, Abell, CW & Maas, JW 1989, 'The effect of debrisoquin on MAO A and MAO B activities', Life Sciences, vol. 45, no. 24, pp. 2359-2364. https://doi.org/10.1016/0024-3205(89)90118-5
Javors, Martin A ; Bembenek, M. E. ; Bowden, C. L. ; Abell, C. W. ; Maas, J. W. / The effect of debrisoquin on MAO A and MAO B activities. In: Life Sciences. 1989 ; Vol. 45, No. 24. pp. 2359-2364.
@article{5220e097e0ef41f4be6d13aa94d97a6c,
title = "The effect of debrisoquin on MAO A and MAO B activities",
abstract = "To examine the mode of action of debrisoquin (DEB), we studied the effect of this drug in vitro on MAO A and MAO B enzyme activities. DEB was shown to be a competitive inhibitor of highly purified human MAO A and MAO B enzyme activities. DEB inhibited placental MAO A with a Ki value of 0.5 μM and liver MAO B with a Ki value of 8.8 μM, 18-fold greater effect on the A form. Kynuramine was used as substrate for both enzymes. Additional studies using a dilution technique showed that DEB was a reversible inhibitor of both forms of the enzyme. The results of this study show that DEB is a potent competitive and reversible inhibitor of both MAO A and MAO B enzymes.",
author = "Javors, {Martin A} and Bembenek, {M. E.} and Bowden, {C. L.} and Abell, {C. W.} and Maas, {J. W.}",
year = "1989",
doi = "10.1016/0024-3205(89)90118-5",
language = "English (US)",
volume = "45",
pages = "2359--2364",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "24",

}

TY - JOUR

T1 - The effect of debrisoquin on MAO A and MAO B activities

AU - Javors, Martin A

AU - Bembenek, M. E.

AU - Bowden, C. L.

AU - Abell, C. W.

AU - Maas, J. W.

PY - 1989

Y1 - 1989

N2 - To examine the mode of action of debrisoquin (DEB), we studied the effect of this drug in vitro on MAO A and MAO B enzyme activities. DEB was shown to be a competitive inhibitor of highly purified human MAO A and MAO B enzyme activities. DEB inhibited placental MAO A with a Ki value of 0.5 μM and liver MAO B with a Ki value of 8.8 μM, 18-fold greater effect on the A form. Kynuramine was used as substrate for both enzymes. Additional studies using a dilution technique showed that DEB was a reversible inhibitor of both forms of the enzyme. The results of this study show that DEB is a potent competitive and reversible inhibitor of both MAO A and MAO B enzymes.

AB - To examine the mode of action of debrisoquin (DEB), we studied the effect of this drug in vitro on MAO A and MAO B enzyme activities. DEB was shown to be a competitive inhibitor of highly purified human MAO A and MAO B enzyme activities. DEB inhibited placental MAO A with a Ki value of 0.5 μM and liver MAO B with a Ki value of 8.8 μM, 18-fold greater effect on the A form. Kynuramine was used as substrate for both enzymes. Additional studies using a dilution technique showed that DEB was a reversible inhibitor of both forms of the enzyme. The results of this study show that DEB is a potent competitive and reversible inhibitor of both MAO A and MAO B enzymes.

UR - http://www.scopus.com/inward/record.url?scp=0024351638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024351638&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(89)90118-5

DO - 10.1016/0024-3205(89)90118-5

M3 - Article

VL - 45

SP - 2359

EP - 2364

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 24

ER -